生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
PANC-1(RCB2095)
,
PK-59(RCB1901)
|
78765
|
Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines.
|
Cancer Sci |
2023-11-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
SSP-25(RCB1293)
|
76426
|
Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.
|
Int J Biol Sci |
2023-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
SSP-25(RCB1293)
,
RBE(RCB1292)
,
YSCCC(RCB1549)
,
TGBC24TKB(RCB1196)
,
TFK-1(RCB2537)
|
67146
|
Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
|
Dis Model Mech |
2018-5-14 |
Pubmed
Full text
|
ヒト・動物細胞
|
HS-Sch-2(RCB2230)
,
YST-1(RCB2136)
,
HS-PSS(RCB2362)
|
66113
|
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
|
Mol Oncol |
2017-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MBT-2(RCB0544)
|
65476
|
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC.
|
J Thorac Oncol |
2019-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MIA Paca2(RCB2094)
,
PANC-1(RCB2095)
|
65404
|
Clinical relevance of CD70 expression in resected pancreatic cancer: Prognostic value and therapeutic potential.
|
Pancreatology |
2021-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
M-MOK(RCB2534)
|
57794
|
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
|
Nat Commun |
2019-5-16 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
|
54783
|
Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
|
PLoS One |
2018-12-17 |
Pubmed
Full text
|
ヒト・動物細胞
|
TKKK(RCB1907)
,
TGBC24TKB(RCB1196)
,
HuCCT1(RCB1960)
|
52613
|
PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay.
|
Jpn J Clin Oncol |
2018-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Vero(RCB0001)
|
44034
|
Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models.
|
Int J Cancer |
2013-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
RERF-LC-KJ(RCB1313)
,
LC-2/ad(RCB0440)
,
SQ-5(RCB0110)
,
LC-1/sq(RCB0445)
,
LC-1F(RCB0439)
,
RERF-LC-AI(RCB0444)
,
MS-1(RCB0725)
|
42687
|
Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database.
|
BMC Cancer |
2006-6-30 |
Pubmed
Full text
|
ヒト・動物細胞
|
TKKK(RCB1907)
,
TGBC24TKB(RCB1196)
,
HuCCT1(RCB1960)
|
38237
|
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.
|
Cancer Sci |
2010-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PK-1(RCB1972)
,
KLM-1(RCB2138)
|
37526
|
Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway.
|
Cell Death Dis |
2015-6-25 |
Pubmed
Full text
|
ヒト・動物細胞
|
MRC-5 (RCB0211) MRC-5
,
known PDL (RCB0218)
|
18120
|
Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells.
|
Anticancer Res |
2011-4-1 |
Pubmed
|